[c09aa8]: / clusters / 9knumclustersv2 / clust_168.txt

Download this file

76 lines (75 with data), 4.5 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
Active known or suspected autoimmune disease
Participants with active, known, or suspected autoimmune disease
Active, known or suspected autoimmune disease
Active known or suspected exclusionary autoimmune disease
Patients with active, known or suspected autoimmune disease.
Subjects with an active, known, or suspected autoimmune disease
Active, known or suspected autoimmune disease
Participants with active, known or suspected autoimmune disease
Participants with active, known or suspected autoimmune disease
Active, known or suspected autoimmune disease
Active known or suspected autoimmune disease
Participants with active, known or suspected autoimmune disease
Active, known or suspected autoimmune disease.
Patients with an active, known or suspected autoimmune disease
Participants must not have an active, known, or suspected autoimmune disease
Participants with active, known or suspected autoimmune disease
Active known or suspected autoimmune disease
Active known or suspected autoimmune disease
Active, known, or suspected autoimmune disease
No active autoimmune disease or a history of known or suspected autoimmune disease except as detailed in the exclusion criteria below
Active, known, or suspected autoimmune disease or infection
Subjects with active, known, or suspected autoimmune disease are excluded
Subjects with active, known or suspected autoimmune or immunosuppressive disease.
Patients with active known or suspected autoimmune disease or significant autoimmune-related toxicity from prior immuno-oncology therapy
Participants with active, known or suspected autoimmune disease
No active autoimmune disease or a history of known or suspected autoimmune disease
Has active, known, or suspected autoimmune disease
Participants with active, known or suspected autoimmune disease
Known or suspected active organ-threatening autoimmune disease
Active, known or suspected autoimmune disease
Any active, known or suspected autoimmune disease
Patients with active, known or suspected autoimmune disease
Subjects with active, known or suspected autoimmune disease
Patients with active, known or suspected autoimmune disease
Subjects with active, known or suspected autoimmune disease
Subjects with an active, known or suspected autoimmune disease.
Subjects with active, known or suspected autoimmune disease
Active, known, or suspected autoimmune disease
Active, known or suspected autoimmune disease
Active, known or suspected autoimmune disease
Have any active autoimmune disease or a history of known or suspected autoimmune disease;
Active, known, or suspected autoimmune disease
Active, known or suspected autoimmune disease
Participants with active, known, or suspected autoimmune disease
Subjects with active, known or suspected autoimmune disease
Active, known, or suspected autoimmune disease or infection
Active known or suspected autoimmune disease with exceptions noted in protocol.
Subjects with active, known or suspected autoimmune disease
Patients with active, known or suspected autoimmune disease
History of or suspected Gilberts disease (testing not required if presence is not suspected)
Subjects with active, known or suspected autoimmune disease
Active, known or suspected autoimmune disease
Active known or suspected autoimmune disease
Active known or suspected exclusionary autoimmune disease
Active, suspected or prior documented autoimmune disease.
Patients with active known or suspected autoimmune disease (treated hypothyroidism is permitted to enroll)
Subject with active, known or suspected autoimmune disease
Subjects with active, known or suspected autoimmune disease
Active, known or suspected autoimmune disease
Subjects with active, known or suspected autoimmune disease
Active, known or suspected autoimmune disease
Participants with active, known, or suspected autoimmune disease
Subjects with active, known or suspected autoimmune disease
Active, known or suspected autoimmune disease
Any active known or suspected autoimmune disease
Active, known or suspected autoimmune disease
Subjects with an active, known or suspected autoimmune disease are excluded
Patients with active, known or suspected autoimmune disease
Active, known or suspected autoimmune disease.
Active known or suspected autoimmune disease
Subjects with an active, known or suspected autoimmune disease are excluded
No known or suspected breast disease
Subjects with known or suspected breast disease
Has active, known or suspected autoimmune disease.
Active, known or suspected autoimmune disease